SCHEMBL3758330

SCHEMBL3758330

COCC/C(=C\c1c(Cl)c(OC)c2ccccc2c1OC)C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 4/20 0.41
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 1/20 0.36
IDO1 P14902 1/20 0.36
SLC2A1 P11166 2/20 0.36
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HPGD P15428 2/20 0.34
GLA P06280 1/20 0.34
PSMB8 P28062 1/20 0.33
PSMB5 P28074 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
CYP2C19 P33261 1/20 0.33
DRD3 P35462 2/20 0.32
DRD2 P14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3758331 1.00 APEX1 (0.41) APEX1KDM4ECYP1A2CYP2C9IDO1
SCHEMBL3806858 0.90 APEX1 (0.52) APEX1KDM4ECYP1A2CYP2C9IDO1
SCHEMBL3806859 0.90 APEX1 (0.52) APEX1KDM4ECYP1A2CYP2C9IDO1
SCHEMBL13080077 0.90 APEX1 (0.52) APEX1KDM4ECYP1A2CYP2C9IDO1
SCHEMBL13080429 0.88 APEX1 (0.39) APEX1KDM4ECYP1A2CYP2C9IDO1
SCHEMBL16938349 0.86 APEX1 (0.40) APEX1KDM4ECYP1A2CYP2C9IDO1
SCHEMBL13080054 0.80 MAPT (0.41) KDM4ESLC2A1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL13079653 0.80 MAPT (0.41) KDM4ESLC2A1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL3751223 0.80 APEX1 (0.40) APEX1KDM4ECYP1A2CYP2C9IDO1
SCHEMBL13080052 0.80 APEX1 (0.40) APEX1KDM4ECYP1A2CYP2C9IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203161-B1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF UNIV INDIANA RES & TECH CORP (US) 2018-05-09 EP disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 APEX1 1/4885KDM4E 2642/4885CYP1A2 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.